Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential
TipRanksApr 2 15:45 ET
Femasys Analyst Ratings
BenzingaApr 1 06:41 ET
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12
BenzingaApr 1 06:43 ET
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)
TipRanksMar 21 14:30 ET
Femasys Analyst Ratings
BenzingaMar 21 12:52 ET
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
TipRanksMar 21 06:31 ET
Femasys Analyst Ratings
BenzingaMar 21 06:28 ET
Femasys (FEMY): Solid Financials and Promising Product Developments Reinforce Buy Rating
TipRanksNov 15, 2023 12:35 ET
Promising Financial and Clinical Prospects Propel Femasys to a 'Buy' Rating by Chardan Capital
TipRanksNov 14, 2023 21:45 ET
HC Wainwright & Co. Maintains Buy on Femasys, Lowers Price Target to $10
BenzingaNov 14, 2023 11:20 ET
Femasys Analyst Ratings
BenzingaNov 14, 2023 11:18 ET
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BerGenBio AS (BRRGF)
TipRanksNov 14, 2023 10:50 ET
Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Femasys (FEMY)
TipRanksNov 14, 2023 10:40 ET
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $13
BenzingaSep 29, 2023 06:26 ET
Femasys Analyst Ratings
BenzingaSep 29, 2023 06:25 ET
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Femasys (FEMY) and ImmunoGen (IMGN)
TipRanksSep 29, 2023 06:20 ET
Analysts Offer Insights on Healthcare Companies: Organogenesis Holdings (ORGO) and Femasys (FEMY)
TipRanksSep 28, 2023 07:40 ET
JonesTrading Maintains Buy on Femasys, Raises Price Target to $7
BenzingaSep 26, 2023 10:10 ET
Femasys Analyst Ratings
BenzingaSep 26, 2023 10:05 ET
Maxim Group Reaffirms Their Buy Rating on Femasys (FEMY)
TipRanksAug 11, 2023 11:25 ET
No Data
No Data